Brain-Computer Interfaces: Germany Hacks the Nervous System with Dr. Martin Schüttler | RC102

In this episode of Rebelliously Curious, host Chrissy Newton engages in a deep and nuanced conversation with Dr. Martin Schüttler, co-founder and CTO of Cortec, Germany's first brain-computer interface (BCI) company. The discussion explores the cutting-edge world of neurotechnology, focusing on how BCIs are transitioning from science fiction to clinical reality—particularly in restoring function for people with severe disabilities like ALS and spinal cord injuries. Schüttler shares his 30-year journey into neural technology, highlighting the pivotal role of epilepsy monitoring units in early BCI research and the company’s focus on robust, long-term electrocorticography signals rather than high-resolution neuron-level interfaces. A central theme is the therapeutic potential of BCIs beyond communication, including real-time brain stimulation for stroke recovery and mental health conditions like depression, where treatment could be personalized based on live brain data. The episode also confronts the profound ethical and privacy challenges: who owns brain data, how it could be exploited by insurers or governments, and the risk of emotional manipulation or social stratification through 'neuro-elite' divides. Schüttler contrasts Europe’s cautious, ethics-driven approach with China’s rapid regulatory rollout and global ambitions, while cautioning against BCI tourism and the need for international standards. The conversation ends on a reflective note—balancing the life-changing promise of BCIs with the existential questions they raise about human identity, autonomy, and the future of consciousness.